Learn More
TARGETMOL CHEMICALS INC RESIQUIMOD 50MG

Supplier: TARGETMOL CHEMICALS INC T6964

Also available in 5 mg 10 mg 25 mg 100 mg 200 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. Resiquimod (R848) is an imidazoquinoline amine and Toll-like receptor (TLR) agonist with potential immune response modifying activity. Resiquimod exerts its effect through the TLR signaling pathway by binding to and activating TLR7 and 8 mainly on dendritic cells macrophages and B-lymphocytes. This induces the nuclear translocation of the transcription activator NF-kB as well as activation of other transcription factors. This may lead to an increase in mRNA levels and subsequent production of cytokines especially interferon-alpha (INF-a) and other cytokines thereby enhancing T-helper 1 (Th1) immune responses. In addition topical application of resiquimod appears to activate Langerhans' cells leading to an enhanced activation of T-lymphocytes. purity: 99%
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.